C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells.
C60 carboxyfullerene is a novel buckminsterfullerene-derived compound that behaves as a free-radical scavenger. In the present report, we investigated whether this drug exerts a protective activity against oxidative stress-induced apoptosis. Human peripheral blood mononuclear cells (PBMCs) were challenged by 2-deoxy-d-ribose (dRib) or TNF-alpha plus cycloheximide as agents that trigger apoptosis by interfering with the redox status of cell and mitochondrial membrane potential. We found that carboxyfullerene was able to protect quiescent PBMCs from apoptosis caused either by 2-deoxy-d-ribose or TNF-alpha plus cycloheximide by a mechanism partially involving the mitochondrial membrane potential integrity, known to be associated with early stages of apoptosis. These results represent the first indication for a target activity of buckminsterfullerenes on cells of the immune system and their mitochondria.
Monti
D
D
Department of Experimental Pathology and Oncology, University of Florence, Florence, Italy. daniela.monti@unifi.it
Moretti
L
L
Salvioli
S
S
Straface
E
E
Malorni
W
W
Pellicciari
R
R
Schettini
G
G
Bisaglia
M
M
Pincelli
C
C
Fumelli
C
C
Bonafè
M
M
Franceschi
C
C
D000328:Adult; D017209:Apoptosis; D002264:Carboxylic Acids / Q000494:pharmacology*; D037741:Fullerenes; D006801:Humans; D066298:In Vitro Techniques; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects*; D018384:Oxidative Stress / Q000187:drug effects*; D020011:Protective Agents / Q000494:pharmacology*
C416673:C60 carboxyfullerene; D002264:Carboxylic Acids; D037741:Fullerenes; D020011:Protective Agents